Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 4Thoracic 1Other solid neoplasm 1Endocrine 1Dermatologic 1

Conditions

Lung Neoplasms 29Carcinoma, Non-Small-Cell Lung 23Urinary Bladder Neoplasms 4Melanoma 4Colorectal Neoplasms 3Carcinoma, Renal Cell 3Adenocarcinoma of Lung 3Uterine Neoplasms 2Uterine Cervical Neoplasms 2Urogenital Neoplasms 2Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Colitis 2Carcinoma, Neuroendocrine 2Carcinoma, Merkel Cell 2Carcinoma, Hepatocellular 2Urethral Neoplasms 1Ureteral Neoplasms 1Turcot syndrome 1Thyroid Neoplasms 1Stomach Neoplasms 1Rectal Neoplasms 1Radiation Pneumonitis 1Ovarian Neoplasms 1Neoplasm Metastasis 1

Interventions

pembrolizumab 4spartalizumab 2toripalimab 1tislelizumab 1atezolizumab 1Quality of Life 1Pemetrexed 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Ipilimumab 1Immunotherapy 1Immunoglobulin G 1Drug Therapy 1Disulfides 1Biological Therapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nasopharyngeal Carcinoma × Immunoglobulin G × Thoracic × Clear all
NCT03074513 2026-03-11

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
133 enrolled
DermatologicEndocrineHead & NeckOther solid neoplasmThoracic

Nasopharyngeal Carcinoma, Mesothelioma, Malignant, Adenocarcinoma, Mucinous, Adenoma, Islet Cell, Nasopharyngeal Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡